Research projects
Cima Universidad de Navarra
-
Hepatology: Carcinogenesis and Liquid BiopsyActive
Characterisation of the therapeutic potential of the SLU7-TAZ-AREG axis in liver cancer (SLUTAREG)
Cima Principal Investigator: Carmen Berasain Lasarte -
Gene Therapy in Neurological DiseasesActive
Restoring Lipid Homeostasis in Neurodegeneration: From Fundamental Mechanisms to Therapeutic Translation
Cima Principal Investigator: Ana Mª García Osta -
Immune TherapiesActive
Development of HLA-independent T cells redirected by nanoantibodies as a new therapeutic strategy for multiple myeloma. HINT4MM
Cima Principal Investigator: Juan Roberto Rodríguez Madoz -
Radioimmunotherapy strategies for pediatric tumorsActive
Study of neuroimmune interactions to prevent radiotherapy-induced cognitive impairment in paediatric brain tumours. (NeuroImmunePed)
Cima Principal Investigator: Sara Labiano Almiñana -
Hepatology: Metabolism, Epigenetics and CarcinogenesisActive
New epigenetic mechanisms and therapeutic strategies in cholangiocarcinoma. EPICHOL
Cima Principal Investigator: Matías Ávila Zaragozá -
Immunomodulation and Tumor MicroenvironmentActive
Understanding the tumour microenvironment for the optimised development of immunotherapies
Cima Principal Investigator: Juan José Lasarte -
Renal Gene Therapy and Chimeric AAV DevelopmentActive
Engineering of AAV Vectors for Gene Therapy to Treat Polycystic Kidney Disease: Adaptation to Disease Progression. (AAV-PKD)
Cima Principal Investigator: Rafael Aldabe Arregui -
Intracavitary ImmunotherapyActive
Modified Immunocytokine mRNAs Targeting the Omentum as a New Locoregional Immunotherapy for Peritoneal Metastases
Cima Principal Investigator: Fernando Aranda VegaFunder: Ministerio de Ciencia, Innovación y UniversidadesAward year 2026 -
Tumor Evasion and New TargetsActive
Ionizing Radiation and Adeno-Associated Viral Vectors: A New Approach to Precision Medicine in Cancer
Cima Principal Investigator: Juan Dubrot ArmendárizFunder: Ministerio de Ciencia, Innovación y UniversidadesAward year 2026 -
Myeloid PathologyActive
Research project titled “Master Transcription Regulators and Key Effector Genes as Therapeutic Targets for High-Risk Myelodysplastic Syndromes,” conducted by the Myeloid Pathology research group at the CIMA Center, University of Navarra. Grant CNS2025-166877 funded by MICIU/AEI /10.13039/501100011033
Cima Principal Investigator: Teresa Ezponda ItoizFunder: Ministerio de Ciencia, Innovación y UniversidadesAward year 2026